(907) 267-5890
Advanced Dermatology of Alaska logo
Back to all articles
Advanced Dermatology of Alaska

Acne · Patient Guide

Isotretinoin for Severe Acne: What to Expect, From iPLEDGE to Your Last Pill

Who isotretinoin helps, how a course of treatment works, side effects and how to manage them, and the iPLEDGE changes that took effect November 15, 2026, from the dermatology team at our Anchorage, Wasilla, and Juneau clinics.

By Advanced Dermatology of Alaska · November 15, 2026

Isotretinoin is a prescription medicine for severe acne (American Academy of Dermatology). For many people, it is the treatment that finally clears acne that nothing else could. It also takes planning: monthly prescriptions, blood tests, and, for patients who can get pregnant, strict pregnancy prevention through a national safety program called iPLEDGE.

Our board-certified dermatologists and SDPA Dermatology Trained physician assistants prescribe isotretinoin and guide patients through every step at our clinics in Anchorage, Wasilla, and Juneau. This guide explains who it is for, what to expect, how to manage side effects, and what changed in the iPLEDGE program on November 15, 2026.

Who isotretinoin is for

The American Academy of Dermatology's acne guidelines strongly recommend isotretinoin for acne that is severe, acne that causes scarring or emotional distress, and acne that has not improved with standard treatments taken by mouth or applied to the skin (Journal of the American Academy of Dermatology). Your dermatologist will decide with you whether it is a good option.

How well it works

Treatment with isotretinoin often results in long-lasting clearance of acne, which can be permanent for some people (American Academy of Dermatology). If acne does not clear after one course, a second course may be an option, after a break of at least 8 weeks (American Academy of Dermatology).

What a course of treatment looks like

iPLEDGE and what changed on November 15, 2026

Everyone who takes isotretinoin is enrolled in iPLEDGE, a safety program that helps make sure no one starts isotretinoin while pregnant or becomes pregnant during treatment (American Academy of Dermatology). In February 2026, the FDA approved changes to iPLEDGE that make it easier to follow (Healio). The changes took effect November 15, 2026, after the FDA moved the start date from August to allow more time to test the iPLEDGE system (U.S. Food and Drug Administration).

If you can get pregnant

  • Birth control: you must use two approved forms of birth control or not have sex or any sexual contact (American Academy of Dermatology), for the full time iPLEDGE requires before, during, and after treatment.
  • Pregnancy tests: you take a pregnancy test before you start and every 30 days to get a refill (American Academy of Dermatology).
  • New: home testing is now a permanent option. Your pregnancy tests before you start must still be done in a medical setting. After your first dose, your dermatologist may allow you to take your monthly pregnancy tests at home, with a process to confirm the results (Healio). Home testing during treatment had been allowed under a temporary FDA policy since the COVID-19 public health emergency (U.S. Food and Drug Administration).
  • New: no waiting period after a missed pickup. You still have 7 days to pick up each prescription. If you miss that window, you can now take a new pregnancy test right away instead of waiting. If you had not yet received your first dose, that repeat test must be done in a medical setting (Dermatology Times).

If you cannot get pregnant

  • New: fewer monthly steps. Your dermatologist no longer has to document your counseling in iPLEDGE every month, and your prescription no longer has a 30-day pickup window. Each prescription is still limited to a 30-day supply (Healio). Your dermatologist will still counsel you at the start and during treatment, and will still check on you with follow-up visits and blood tests.

Common side effects and how to manage them

Dry skin, chapped lips, dry and irritated eyes, and nosebleeds are common while taking isotretinoin (American Academy of Dermatology). Dermatologists recommend:

  • Lips: use a lip balm with SPF 30 or higher when you go outdoors, and petroleum jelly indoors.
  • Skin: apply an oil-free moisturizer after washing.
  • Eyes: use saline eye drops or artificial tears.
  • Nose: use a moisturizing nasal spray, or dab a very small amount of petroleum jelly just inside your nostrils.

Other temporary side effects can include muscle or joint pain and trouble seeing at night. These side effects, and the dryness, tend to go away once you stop isotretinoin (American Academy of Dermatology).

Isotretinoin also makes your skin more sensitive to the sun, so you can sunburn quickly and unexpectedly. Seek shade, wear protective clothing, apply sunscreen, and avoid tanning beds (American Academy of Dermatology).

If you are taking isotretinoin during an Alaska winter, our guide to dry skin and dry scalp in Alaska has more tips.

Serious risks

  • Birth defects. Taking isotretinoin while pregnant can cause severe birth defects, miscarriage, stillbirth, and premature birth (American Academy of Dermatology). That is why iPLEDGE exists.
  • Mood changes. Before prescribing isotretinoin, dermatologists carefully screen for signs of depression and thoughts of suicide. If you notice any change in your mood, tell your dermatologist right away. Research on this question is mixed, and more studies are needed to understand who is most at risk (American Academy of Dermatology).
  • Bowel problems. More studies are needed to know whether inflammatory bowel disease is a possible side effect of isotretinoin (American Academy of Dermatology).

If you ever have thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, or call 911.

Things to avoid during treatment

Getting started with us

Our board-certified dermatologists and SDPA Dermatology Trained physician assistants prescribe isotretinoin and manage iPLEDGE requirements at all three of our clinics. Same-week appointments are available, and we are in-network with all major insurance plans, commercial and government.

Anchorage

Our Anchorage clinic at 1100 E Dimond Blvd, Anchorage, AK 99515, serves patients from Eagle River, Chugiak, and the rest of the Anchorage area.

Wasilla, Palmer, and the Mat-Su Valley

Our Wasilla clinic at 3066 E Meridian Park Loop, Wasilla, AK 99654, serves patients from Palmer and across the Mat-Su Valley.

Juneau

Our Juneau clinic is inside Bartlett Regional Hospital Specialty Clinics at 3268 Hospital Drive, Juneau, AK 99801.

We are here to help

Ready to talk about isotretinoin? Call us at (907) 267-5890 or request an appointment online.

Serving Wasilla, Palmer, Anchorage, Juneau & the Mat-Su Valley

Frequently asked questions

QR code linking to the isotretinoin patient guide

Scan to revisit this page

Point your phone camera here to reopen this guide anytime.

Medical disclaimer

This guide was prepared by the dermatology team at Advanced Dermatology of Alaska using information from the American Academy of Dermatology, the U.S. Food and Drug Administration, and peer-reviewed medical research and news. iPLEDGE requirements can change, and this guide reflects the program as of November 15, 2026. This guide is for general education and does not replace individualized medical care. For advice about your own skin and treatment, contact your healthcare provider.

Selected references

  1. American Academy of Dermatology. Isotretinoin: Overview. Updated September 12, 2023.
  2. American Academy of Dermatology. Isotretinoin: FAQs. Updated September 12, 2023.
  3. American Academy of Dermatology. Isotretinoin: The truth about safety, side effects, and skin care. Updated September 22, 2025.
  4. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30.
  5. Healio. FDA approves changes to iPLEDGE pregnancy test requirements for isotretinoin. February 11, 2026.
  6. Dermatology Times. FDA updates iPLEDGE REMS with new modifications for pregnancy testing and prescription windows. February 10, 2026.
  7. U.S. Food and Drug Administration. Implementation for iPLEDGE REMS modifications delayed until November. June 16, 2026.
  8. U.S. Food and Drug Administration. iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). Content current as of November 16, 2026.